USP chapter <787>, Subvisible Particulate Matter in Therapeutic Protein Injections, became official August 1, 2014 and provides specific guidance for testing the final dose form of protein-based ...

A revised version of the USP chapter on Subvisible Particulate Matter USP<1788> became official on 1 st May 2021. USP<1788> is meant to expand on the information given in the chapters <787>, <788> and ...

An update to USP<1788> Methods for Determination of Subvisible Particulate Matter was released in May 2021. Its goal is to assist in the support and clarification of the information provided in ...

Particulate matter found in injectable drugs is measured in the visible and sub-visible ranges. In the sub-visible range, measurements are generally made by liquid particle counter, or by microscopic ...